NEW ZEALAND GAZETTE, No. 157

29 OCTOBER 2009

The applicant’s address for service is:

Pfizer New Zealand Limited, Level 3, Pfizer House, 14 Normanby Road, Mt Eden, Auckland 1024. Postal Address: PO Box 3998, Shortland Street, Auckland 1140.

Dated at Wellington this 23rd day of October 2009.

MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority), New Zealand Food Safety Authority.

go8948

Notice of Application to Register a Trade Name Product (Notice No. 179)

Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), the Director-General of the New Zealand Food Safety Authority gives notice that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Zapp Encore

Reference: A10400

Active Ingredients and Concentrations:

Triflumuron 26.875g/L

Imidacloprid 30.0g/L

Formulation Type: Oily solution

General Use Claim: For the knockdown control of body lice (Bovicola ovis) on all breeds of sheep and for treatment and protection against flystrike (including Lucilia cuprina) in coarse wool breeds of sheep.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.

The applicant’s address for service is:

Bayer New Zealand Limited, 3 Argus Place, Hillcrest, North Shore City 0627. Postal Address: PO Box 2825, Shortland Street, Auckland 1140.

Dated at Wellington this 23rd day of October 2009.

MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority), New Zealand Food Safety Authority.

go8949

Police

Land Transport Act 1998

Land Transport (Compulsory Impairment Test) Notice 2009

Pursuant to section 2(1) of the Land Transport Act 1998, the Minister of Police gives the following notice.

Notice

1. Title

This notice is the Land Transport (Compulsory Impairment Test) Notice 2009.

2. Commencement

This notice comes into force on 1 November 2009.

3. Interpretation

In this notice:

officer means an enforcement officer who is trained to give the compulsory impairment test;

testing officer means the officer who is giving the compulsory impairment test.

4. Compulsory impairment test

The compulsory impairment test comprises all the activities described in clauses 5 to 8.

5. Disclosure of medical condition or disability

(1) At the start of the compulsory impairment test, the testing officer must advise the person being tested of that person’s obligation under subclause (2).

(2) Before or at any time during the compulsory impairment test, the person being tested must disclose to the testing officer any medical condition or disability that he or she has that could affect:

(a) the person’s ability to complete the test; or

(b) the outcome of the test.

6. Eye assessment

(1) Step 1: Preliminary action—

(a) If the person being tested is wearing any form of eyeglasses:

(i) the testing officer must direct the person to remove his or her eyeglasses; and

(ii) the person must then immediately remove his or her eyeglasses.

(b) The testing officer must ask the person being tested whether the person is wearing contact lenses and the person being tested must reply to that question.

(2) Step 2: Eye assessment—

(a) The testing officer must:

(i) direct the person being tested to keep his or her head still; and

(ii) when the person being tested has his or her head still:

(A) measure the person’s pupils by comparing them with a gauge held beside the person’s eyes; and

(B) investigate the reaction of the person’s eyes to light using torchlight.